WP
COGT icon

Woodline Partners’s Cogent Biosciences COGT Stock Holding History

Woodline Partners’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.1M Buy
1,509,557
+690,775
+84% +$25.5M 0.22% 113
2025
Q4 		$29.1M Buy
818,782
+305,385
+59% +$8.58M 0.11% 236
2025
Q3 		$7.37M Sell
513,397
-487,214
-49% -$5.77M 0.03% 497
2025
Q2 		$7.18M Sell
1,000,611
-686,929
-41% -$3.81M 0.04% 492
2025
Q1 		$10.1M Buy
1,687,540
+1,074,375
+175% +$8.42M 0.07% 360
2024
Q4 		$4.78M Buy
613,165
+12,589
+2% +$125K 0.03% 494
2024
Q3 		$6.49M Buy
600,576
+478
+0.1% +$4.65K 0.05% 358
2024
Q2 		$5.06M Sell
600,098
-98,280
-14% -$745K 0.05% 338
2024
Q1 		$4.69M Sell
698,378
-92,106
-12% -$569K 0.04% 368
2023
Q4 		$4.65M Buy
790,484
+670,484
+559% +$5.14M 0.05% 326
2023
Q3 		$1.17M Buy
+120,000
New +$1.42M 0.01% 434
2022
Q4 		– Sell
-69,871
Closed -$1.04M – 769
2022
Q3 		$1.04M Buy
+69,871
New +$958K 0.01% 530
2022
Q2 		– Sell
-36,783
Closed -$276K – 812
2022
Q1 		$276K Buy
+36,783
New +$256K ﹤0.01% 536

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Woodline Partners's COGT Position: Q1 2026 in Review

Woodline Partners increased its Cogent Biosciences (COGT) stake by 84% in Q1 2026, buying an estimated $25.5M and bringing the position to 1,509,557 shares worth $58.1M. The position accounts for 0.22% of the portfolio, ranked #113.

Woodline Partners first reported a position in COGT in Q1 2022 and has held it in 13 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Woodline Partners held 1,509,557 shares of Cogent Biosciences worth $58.1M as of Q1 2026.
  • Woodline Partners bought 690,775 Cogent Biosciences shares in Q1 2026, an estimated $25.5M.
  • Cogent Biosciences made up 0.22% of Woodline Partners's portfolio in Q1 2026, its #113 holding.
  • Woodline Partners first reported a position in Cogent Biosciences in Q1 2022 and has held it in 13 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.